Javascript must be enabled to continue!
Experiences with risk-reducing mastectomy in Norwegian BRCA1/2 carriers without prior breast cancer
View through CrossRef
Abstract
Background:
BRCA1
and
BRCA2
carriers without prior breast cancer have the option to undergo risk-reducing mastectomy (RRM). The aim of this study was to investigate factors associated with their decision, experiences with the process, and satisfaction with the procedure.
Materials and methods:
We distributed a cross-sectional survey to 425 women aged 25–70 with a pathogenic
BRCA1/2
variant. The survey collected data on sociodemographic factors, family cancer history, reasons for choosing RRM or not, experiences with the decision-making process, support from healthcare, and surgery satisfaction. Multivariate logistic regression analysis identified factors associated with the decision to undergo RRM and satisfaction with having undergone surgery.
Results:
Of the 272 respondents, 190 (69.9%) had undergone RRM. Having children and being a
BRCA1
carrier were both associated with higher probability of choosing RRM, with an OR of 3.5 (
p
= 0.005 and
p
< 0.001 respectively). Among those who had undergone RRM, 78.9% (150/190) were satisfied with their decision and would choose the same procedure again. Feeling satisfied with support from the health care system gave an OR of 5.5 for being satisfied with having undergone RRM (
p
< 0.01). Those who found the decision difficult had lower odds of being satisfied (OR 0.2,
p
= 0.02).
Conclusion:
Being a
BRCA1
carrier and having children were strongly associated with choosing RRM. Most participants felt relieved after RRM, were satisfied with their decision, and would choose the surgery again. Support from healthcare providers during decision-making was linked to higher satisfaction with having undergone surgery while those who struggled with the decision reported lower satisfaction.
Springer Science and Business Media LLC
Title: Experiences with risk-reducing mastectomy in Norwegian BRCA1/2 carriers without prior breast cancer
Description:
Abstract
Background:
BRCA1
and
BRCA2
carriers without prior breast cancer have the option to undergo risk-reducing mastectomy (RRM).
The aim of this study was to investigate factors associated with their decision, experiences with the process, and satisfaction with the procedure.
Materials and methods:
We distributed a cross-sectional survey to 425 women aged 25–70 with a pathogenic
BRCA1/2
variant.
The survey collected data on sociodemographic factors, family cancer history, reasons for choosing RRM or not, experiences with the decision-making process, support from healthcare, and surgery satisfaction.
Multivariate logistic regression analysis identified factors associated with the decision to undergo RRM and satisfaction with having undergone surgery.
Results:
Of the 272 respondents, 190 (69.
9%) had undergone RRM.
Having children and being a
BRCA1
carrier were both associated with higher probability of choosing RRM, with an OR of 3.
5 (
p
= 0.
005 and
p
< 0.
001 respectively).
Among those who had undergone RRM, 78.
9% (150/190) were satisfied with their decision and would choose the same procedure again.
Feeling satisfied with support from the health care system gave an OR of 5.
5 for being satisfied with having undergone RRM (
p
< 0.
01).
Those who found the decision difficult had lower odds of being satisfied (OR 0.
2,
p
= 0.
02).
Conclusion:
Being a
BRCA1
carrier and having children were strongly associated with choosing RRM.
Most participants felt relieved after RRM, were satisfied with their decision, and would choose the surgery again.
Support from healthcare providers during decision-making was linked to higher satisfaction with having undergone surgery while those who struggled with the decision reported lower satisfaction.
Related Results
Coexisting Granulomatous Mastitis and Breast Cancer: A Systematic Review
Coexisting Granulomatous Mastitis and Breast Cancer: A Systematic Review
Abstract
Introduction: Granulomatous mastitis (GM) is a rare inflammatory breast disease that mimics carcinoma. GM can coexist with breast cancer (BC), though the relationship rema...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Abstract 1716: Evaluating the functional impacts of the BRCA1-mTORC2 interaction in breast cancer
Abstract 1716: Evaluating the functional impacts of the BRCA1-mTORC2 interaction in breast cancer
Abstract
Objective: The BRCA1 C-Terminal (BRCT) domain of BRCA1 has been found to interact with three accessory proteins (PRR5, RICTOR, and SIN1) of mTOR complex ...
Abstract 1563: Damage-induced BRCA1 phosphorylation contributes to the timing of end resection
Abstract 1563: Damage-induced BRCA1 phosphorylation contributes to the timing of end resection
Abstract
Germline mutations of BRCA1 predispose women to breast and ovarian cancers. BRCA1 functions as a tumor suppressor. A wealth of evidence has established that...
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract
Women with one or more first-degree female relatives with a history of breast cancer have a two-fold increased risk of developing breast cancer. This risk i...
Desmoid-Type Fibromatosis of The Breast: A Case Series
Desmoid-Type Fibromatosis of The Breast: A Case Series
Abstract
IntroductionDesmoid-type fibromatosis (DTF), also called aggressive fibromatosis, is a rare, benign, locally aggressive condition. Mammary DTF originates from fibroblasts ...
Abstract 1453: Transcriptoma analyses in triple-negative breast cancer with BRCA1 germline mutation
Abstract 1453: Transcriptoma analyses in triple-negative breast cancer with BRCA1 germline mutation
Abstract
Triple-negative breast cancer (TNBC), characterized by lack of expression of the estrogen receptor (ER), progesterone receptor (PR) and human epidermal grow...
Estrogen Rececptor (ER)-Positive Breast Cancers in BRCA1 Mutation Carriers: Mutation-Related or Sporadic?
Estrogen Rececptor (ER)-Positive Breast Cancers in BRCA1 Mutation Carriers: Mutation-Related or Sporadic?
Abstract
Background: Most invasive breast cancers (IBC) in BRCA1 mutation carriers are ER negative (-) and have a basal-like phenotype by expression array analysis. ...

